de Beaurepaire R: Questions raised by the cytokine hypothesis of depression. Brain Behav Immun 2002;16:610.
Dhillon S, Scott LJ, Plosker GL: Escitalopram: A review of its use in the management of anxiety disorders. CNS Drugs 2006;20:763.
Dhillon S, Yang LP, Curran MP: Bupropion: A review of its use in the management of major depressive disorder. Drugs 2008;68:653.
Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116.
Dvir Y, Smallwood P: Serotonin syndrome: A complex but easily avoidable condition. Gen Hosp Psychiatry 2008;30:284.
Fontenelle LF et al: An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opin Pharmacother 2007;8:563.
Geisser ME et al: A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia. Pain Pract 2011;11:120.
Gether U et al: Neurotransmitter transporters: Molecular function of important drug targets. Trends Pharmacol Sci 2006;27:375.
Gillespie CF, Nemeroff CB: Hypercortisolemia and depression. Psychosom Med 2005;67(Suppl 1):S26.
Gillman PK: A review of serotonin toxicity data: Implications for the mechanisms of antidepressant drug action. Biol Psychiatry 2006;59:1046.
Gillman PK: Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 2007;151:737.
Giner L et al: Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: An update. Int J Adolesc Med Health 2005;17:211.
Guay DR: Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder. Consult Pharm 2012;27:857.
Gutman DA, Owens MJ: Serotonin and norepinephrine transporter binding profile of SSRIs. Essent Psychopharmacol 2006;7:35.
Harrison J, et al: The effects of vortioxetine on cognitive function in patients with major depressive disorder (MDD): A meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol August 24, 2016. [Epub ahead of print]
Hirschfeld RM: Antidepressants in long-term therapy: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000;403:35.
Hirschfeld RM: History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000;61(Suppl 6):4.
Holma KM et al: Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry 2008;69:196.
Jann MW, Slade JH: Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007;27:1571.
Kalia M: Neurobiological basis of depression: An update. Metabolism 2005;54 (5 Suppl 1):24.